Wed, Jun 22, 1:30 PM, Zacks
Prima Reports Favorable Initial Breast Cancer Study Data
Prima BioMed Ltd (PBMD) announced initial data from a phase IIb chemo-immunotherapy study on IMP321 for the treatment of metastatic breast cancer.
Thu, Jun 16, 8:10 AM, Zacks
Company News for June 16, 2016
Companies in the News are BOBE,TWTR,PN,EBIX,CELG